Ticker: RLMD

Company: RELMADA THERAPEUTICS, INC.

Person: Maged Shenouda, officer

Transaction date: Dec. 12, 2025

Reporting date: Dec. 16, 2025

Average share price: 4.12

Bought 11665.0 shares for 48059.8